- Home
- IVVD vs CBFV Comparison
IVVD vs CBFV Comparison
Compare IVVD & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IVVD | CBFV |
|---|---|---|
| Founded | 2020 | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.9M | 189.9M |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | IVVD | CBFV |
|---|---|---|
| Price | $0.97 | $37.59 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $8.75 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 3.5M | 2.9K |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 3.12% |
| EPS Growth | ★ 79.02 | N/A |
| EPS | N/A | ★ 1.54 |
| Revenue | ★ $53,426,000.00 | $43,557,000.00 |
| Revenue This Year | $61.57 | $48.93 |
| Revenue Next Year | $41.42 | $7.97 |
| P/E Ratio | ★ N/A | $24.27 |
| Revenue Growth | ★ 110.47 | N/A |
| 52 Week Low | $0.53 | $30.97 |
| 52 Week High | $3.07 | $38.86 |
Technical Indicators
Market Signals| Indicator | IVVD | CBFV |
|---|---|---|
| Relative Strength Index (RSI) | 59.28 | 51.88 |
| Support Level | $0.69 | $34.10 |
| Resistance Level | $1.02 | $37.79 |
| Average True Range (ATR) | 0.08 | 0.34 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 61.56 | 37.50 |
Price Performance
Historical ComparisonAbout IVVD Invivyd Inc.
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.
About CBFV CB Financial Services Inc.
CB Financial Services Incis a bank holding company headquartered in Carmichaels, Pennsylvania. The company had one reportable segment, community banking services. The Bank also has a loan production office in Allegheny County, a loan production office and a corporate center in Washington County, and an operations center in Greene County, Pennsylvania. The Bank is a community-oriented institution offering residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a variety of deposit products for individuals and businesses in its market area.